The ratio of skeletal muscle mass to visceral fat area is a main determinant linking circulating irisin to metabolic phenotype

被引:43
作者
Hwang, You-Cheol [1 ]
Jeon, Won Seon [2 ]
Park, Cheol-Young [2 ]
Youn, Byung-Soo [3 ]
机构
[1] Kyung Hee Univ, Sch Med, Kyung Hee Univ Hosp Gangdong, Dept Med,Div Endocrinol & Metab, Seoul, South Korea
[2] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Internal Med,Div Endocrinol & Metab, Seoul 110746, South Korea
[3] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Biomed Res Ctr, 877 Bangeojinsunwhando Ro, Ulsan 44033, South Korea
来源
CARDIOVASCULAR DIABETOLOGY | 2016年 / 15卷
基金
新加坡国家研究基金会;
关键词
Irisin; Skeletal muscle; Visceral fat; Glucose tolerance; Insulin sensitivity; SARCOPENIC OBESITY; ADIPOSE-TISSUE; EXERCISE; ASSOCIATION; MYOKINE; PLASMA; SERUM;
D O I
10.1186/s12933-015-0319-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The aims of this study were to investigate whether circulating irisin is associated with favorable metabolic parameters and how the association differs according to body composition in humans. Methods: A total of 424 subjects (233 men and 191 women), aged 23-73 years (mean age 47.1 years), were enrolled from the Seoul Metro City Diabetes Prevention Program. Body composition was determined using an impedance body composition analyzer, and serum irisin level was measured using a commercial kit. Results: Serum irisin was correlated with favorable metabolic parameters including less obese, lower blood pressure and glucose levels and healthy lipid parameters. The skeletal muscle mass to visceral fat area ratio (SVR) was positively correlated with the serum irisin concentration (r = 0.10, P = 0.04). When the study subjects were divided into tertiles according to their SVR, serum irisin was correlated with favorable metabolic phenotypes in those subjects in the upper tertile. However, there were no such correlations in the lower tertile. In addition, serum irisin was inversely related to pre-diabetes/type 2 diabetes (T2D) independent of other risk factor for T2D and insulin resistance [OR (95 % CI); 0.66 (0.49-0.90), P = 0.009]. Conclusions: The compositions of skeletal muscle and visceral fat play key roles in the association between circulating irisin and a patient's metabolic phenotype.
引用
收藏
页数:6
相关论文
共 22 条
  • [1] Irisin - a myth rather than an exercise-inducible myokine
    Albrecht, Elke
    Norheim, Frode
    Thiede, Bernd
    Holen, Torgeir
    Ohashi, Tomoo
    Schering, Lisa
    Lee, Sindre
    Brenmoehl, Julia
    Thomas, Selina
    Drevon, Christian A.
    Erickson, Harold P.
    Maak, Steffen
    [J]. SCIENTIFIC REPORTS, 2015, 5
  • [2] A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
    Bostroem, Pontus
    Wu, Jun
    Jedrychowski, Mark P.
    Korde, Anisha
    Ye, Li
    Lo, James C.
    Rasbach, Kyle A.
    Bostroem, Elisabeth Almer
    Choi, Jang Hyun
    Long, Jonathan Z.
    Kajimura, Shingo
    Zingaretti, Maria Cristina
    Vind, Birgitte F.
    Tu, Hua
    Cinti, Saverio
    Hojlund, Kurt
    Gygi, Steven P.
    Spiegelman, Bruce M.
    [J]. NATURE, 2012, 481 (7382) : 463 - U72
  • [3] Implication of Circulating Irisin Levels with Brown Adipose Tissue and Sarcopenia in Humans
    Choi, Hae Yoon
    Kim, Sungeun
    Park, Ji Woo
    Lee, Nam Seok
    Hwang, Soon Young
    Huh, Joo Young
    Hong, Ho Cheol
    Yoo, Hye Jin
    Baik, Sei Hyun
    Youn, Byung-Soo
    Mantzoros, Christos S.
    Choi, Kyung Mook
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (08) : 2778 - 2785
  • [4] Serum irisin levels in new-onset type 2 diabetes
    Choi, Yeon-Kyung
    Kim, Mi-Kyung
    Bae, Kwi Hyun
    Seo, Hyun-Ae
    Jeong, Ji-Yun
    Lee, Won-Kee
    Kim, Jung-Guk
    Lee, In-Kyu
    Park, Keun-Gyu
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2013, 100 (01) : 96 - 101
  • [5] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497
  • [6] Irisin levels in the progression of diabetes in sedentary women
    Duran, Iffet Dagdelen
    Gulcelik, Nese Ersoz
    Unal, Mustafa
    Topcuoglu, Canan
    Sezer, Sevilay
    Tuna, Mazhar Muslum
    Berker, Dilek
    Guler, Serdar
    [J]. CLINICAL BIOCHEMISTRY, 2015, 48 (18) : 1268 - 1272
  • [7] Association of metabolic parameters and rs726344 in FNDC5 with serum irisin concentrations
    Ebert, T.
    Kralisch, S.
    Wurst, U.
    Scholz, M.
    Stumvoll, M.
    Kovacs, P.
    Fasshauer, M.
    Toenjes, A.
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2016, 40 (02) : 260 - 265
  • [8] Irisin and Myonectin Regulation in the Insulin Resistant Muscle: Implications to Adipose Tissue: Muscle Crosstalk
    Gamas, Luis
    Matafome, Paulo
    Seicaa, Raquel
    [J]. JOURNAL OF DIABETES RESEARCH, 2015, 2015
  • [9] Gavin JR, 1997, DIABETES CARE, V20, P1183
  • [10] FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise
    Huh, Joo Young
    Panagiotou, Grigorios
    Mougios, Vassilis
    Brinkoetter, Mary
    Vamvini, Maria T.
    Schneider, Benjamin E.
    Mantzoros, Christos S.
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2012, 61 (12): : 1725 - 1738